Fulcrum Therapeutics, Inc. (FULC)

10.38 +0.02 (+0.19%) USD  |  NASDAQ  |  Jan 15, 16:00
10.30 -0.08 (-0.77%) After-Hours: 20:00
More

Fulcrum Therapeutics EBITDA Margin Estimates for Current Quarter

EBITDA Margin Estimates for Current Quarter Chart

View EBITDA Margin Estimates for Current Quarter for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Estimates for Current Quarter Range, Past 5 Years

View EBITDA Margin Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin Estimates for Current Quarter Benchmarks

View EBITDA Margin Estimates for Current Quarter Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade
CorMedix, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade